TREA

86598934 - ATTSITE

Follow

Information

  • Trademark
  • 86598934
  • Serial Number
    86598934
  • Filing Date
    April 15, 2015
    9 years ago
  • Transaction Date
    June 11, 2015
    9 years ago
  • Status Date
    June 11, 2015
    9 years ago
  • Location Date
    June 11, 2015
    9 years ago
  • Status Code
    658
  • Current Location
    TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    VIGIL, JACOB EUGENE
  • Attorney Docket Number
    048337-401
    Attorney Name
    David L. May
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ATTSITE
Case File Statements
  • GS0011: Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture, food production, energy conversion, and production of environmentally-friendly chemical solutions; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; Chemical modifiers of gene expression in plants, mammals, fungi and microbes for industrial and agricultural applications; Chemicals and chemical reagents, namely, for production of cells and transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research
  • GS0051: Chemical modifiers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; Pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes
  • GS0401: Custom manufacturing and custom synthesis of genetically engineered DNA, biological organisms, cells, viruses, and special purpose cells to the specifications of others for scientific, research, medical and laboratory use
  • GS0421: Development of new technology for others in the fields of medicine, genetics, therapeutics, biotechnology, agriculture, energy, fuels, biofuels, biochemistry, the chemical industry, and the environment; Development of products being genetic approaches effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of biotechnological processes to regulate, modulate, and characterize cell function or disease states; Research and development services for others in the fields of biotechnology and genetics, namely, genetically engineering DNA, biological organisms, cells, viruses, and special purpose cells for scientific, research, medical and laboratory use; Scientific research and product development services for others in the pharmaceutical, chemical, biochemical, biotechnology, biosensors, bioelectronics, medical, animal therapeutics, energy, fuels, biofuels, and agriculture fields; Gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, and special purpose cells for scientific, research, medical and laboratory use
  • GS0441: Medical services; Medical services, namely, gene therapy services
  • PM0001: ATT SITE; ATT SIGHT
Case File Event Statements
  • 6/11/2015 - 9 years ago
    7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 6/11/2015 - 9 years ago
    6 - PRIORITY ACTION E-MAILED Type: GPRA
  • 6/11/2015 - 9 years ago
    5 - PRIORITY ACTION WRITTEN Type: CPRA
  • 6/5/2015 - 9 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/24/2015 - 9 years ago
    3 - NOTICE OF PSEUDO MARK E-MAILED Type: MPMK
  • 4/23/2015 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 4/18/2015 - 9 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP